A Gene Therapy Strategy To Restore Electrical And Cardiac Function In Arrhythmogenic Right Ventricular Cardiomyopathy
The invention provides and advantage over the current standard of care.
Gene therapy as a therapeutic treatment for ARVC.
Researchers at UC San Diego have developed a novel treatment strategy for ARVC by rescuing the cardiac electrical and physiological dysfunction associated with arrhythmogenic disorders and thereby potentially prolonging life. This strategy is based upon the use of a novel mouse model of ARVC and using gene therapy as a therapeutic to improve cardiac rhythm and function as demonstrated in our mouse model of ARVC by improving electrical, contractile, and potential survival.
State Of Development The current protocol has been developed in an ARVC mouse model. Intellectual Property Info A provisional patent has been submitted and the technology is available for licensing. Tech ID/UC Case 29006/2018-065-0 Related Cases 2018-065-0
美國
